GNE-955, identified by its CAS number 1527523-39-2, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of its potential therapeutic applications. As a small molecule, it is designed to interact with specific biological targets, often related to disease pathways. The compound typically exhibits characteristics such as a defined molecular structure, which influences its solubility, stability, and bioavailability. GNE-955 may possess unique pharmacological properties, including the ability to modulate enzyme activity or receptor interactions, making it a candidate for further investigation in drug development. Its safety profile, including toxicity and side effects, would be assessed through preclinical and clinical studies. Additionally, the compound's synthesis and formulation are critical for its efficacy and delivery in therapeutic settings. Overall, GNE-955 represents a significant area of interest in medicinal chemistry, with ongoing research aimed at elucidating its full potential in treating specific medical conditions.

GNE-955 is a Potent Pan-Pim Inhibitor. GNE-955 is potent and has excellent bioavailability in rat.

GNE-955

1527523-39-2: GNE-955, identified by its CAS number 1527523-39-2, is a chemical compound that has garnered attention in pharmaceutical research, particularly in the context of its potential therapeutic applications. As a small molecule, it is designed to interact with specific biological targets, often related to disease pathways. The compound typically exhibits characteristics such as a defined molecular structure, which influences its solubility, stability, and bioavailability. GNE-955 may possess unique pharmacological properties, including the ability to modulate enzyme activity or receptor interactions, making it a candidate for further investigation in drug development. Its safety profile, including toxicity and side effects, would be assessed through preclinical and clinical studies. Additionally, the compound's synthesis and formulation are critical for its efficacy and delivery in therapeutic settings. Overall, GNE-955 represents a significant area of interest in medicinal chemistry, with ongoing research aimed at elucidating its full potential in treating specific medical conditions.

Please enquire for more information about (3S)-1-[3-Methoxy-6-[6-(6-methylpyrazin-2-yl)pyrazolo[4,3-c]pyridin-1-yl]pyridin-2-yl]piperidin-3-amine including the price, delivery time and more detailed product information at the technical inquiry form on this page

(3S)-1-[3-Methoxy-6-[6-(6-methylpyrazin-2-yl)pyrazolo[4,3-c]pyridin-1-yl]pyridin-2-yl]piperidin-3-amine

GNE-955 is a potent and orally active inhibitor of pan Pim kinase (Kis: 0.018, 0.11, 0.08 nM for Pim1, Pim2, Pim3, respectively).

CAS 1527523-39-2

GNE-955

(3S)-1-[3-Methoxy-6-[6-(6-methylpyrazin-2-yl)pyrazolo[4,3-c]pyridin-1-yl]pyridin-2-yl]piperidin-3-amine

Ref: 3D-CLC52339

GNE-955

Ref: TM-T15406